Home/Filings/4/0000899243-18-006470
4//SEC Filing

Molineaux Christopher 4

Accession 0000899243-18-006470

CIK 0001496671other

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 4:08 PM ET

Size

11.1 KB

Accession

0000899243-18-006470

Insider Transaction Report

Form 4
Period: 2018-03-02
Molineaux Christopher
SR. VP, DEVELOPMENT
Transactions
  • Exercise/Conversion

    Common Stock

    2018-03-02$2.64/sh+6,798$17,94721,000 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2018-03-0226,9929,729 total(indirect: By Spouse)
    Exercise: $2.64Exp: 2023-12-16Common Stock (26,992 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2018-03-026,7980 total
    Exercise: $2.64Exp: 2023-12-16Common Stock (6,798 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    44,860
  • Common Stock

    (indirect: By Trust)
    349,190
Footnotes (3)
  • [F1]Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on December 8, 2017.
  • [F2]Shares are held by the Molineaux Family Trust, of which the Reporting Person is a Trustee.
  • [F3]1/48 of the Option vests in equal monthly installments one month from 12/17/2013. The option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.

Issuer

Calithera Biosciences, Inc.

CIK 0001496671

Entity typeother

Related Parties

1
  • filerCIK 0001618120

Filing Metadata

Form type
4
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:08 PM ET
Size
11.1 KB